Pfizer (NYSE: PFE) was a stock on the move Wednesday, and not because of any news generated by the healthcare company. Reports of a meeting between Pfizer's leader and an activist investor breathed ...

On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low ...

Blue chip stocks are among the safest and most secure buys that investors can add to their portfolios. Here are some of the ...

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030.